HealthEquity Inc. (NASDAQ:HQY) CEO Jon Kessler sold 65,288 shares of the firm’s stock in a transaction dated Monday, September 19th. The shares were sold at an average price of $35.02, for a total transaction of $2,286,385.76. Following the completion of the sale, the chief executive officer now owns 485,288 shares of the company’s stock, valued at approximately $16,994,785.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Jon Kessler also recently made the following trade(s):

  • On Tuesday, September 20th, Jon Kessler sold 54,712 shares of HealthEquity stock. The shares were sold at an average price of $35.07, for a total transaction of $1,918,749.84.
  • On Thursday, September 15th, Jon Kessler sold 20,000 shares of HealthEquity stock. The shares were sold at an average price of $33.46, for a total transaction of $669,200.00.
  • On Monday, September 12th, Jon Kessler sold 120,117 shares of HealthEquity stock. The shares were sold at an average price of $33.10, for a total transaction of $3,975,872.70.
  • On Wednesday, August 31st, Jon Kessler sold 34,883 shares of HealthEquity stock. The shares were sold at an average price of $33.00, for a total transaction of $1,151,139.00.
  • On Monday, July 25th, Jon Kessler sold 10,000 shares of HealthEquity stock. The shares were sold at an average price of $29.62, for a total transaction of $296,200.00.
  • On Friday, July 15th, Jon Kessler sold 10,000 shares of HealthEquity stock. The shares were sold at an average price of $30.05, for a total transaction of $300,500.00.
  • On Thursday, June 23rd, Jon Kessler sold 10,000 shares of HealthEquity stock. The shares were sold at an average price of $29.00, for a total transaction of $290,000.00.

Shares of HealthEquity Inc. (NASDAQ:HQY) traded up 2.12% during mid-day trading on Wednesday, reaching $36.20. 849,136 shares of the company were exchanged. The company’s 50 day moving average price is $31.56 and its 200 day moving average price is $27.76. HealthEquity Inc. has a 12 month low of $15.80 and a 12 month high of $36.80. The firm has a market capitalization of $2.12 billion, a PE ratio of 92.82 and a beta of 1.65.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/jon-kessler-sells-65288-shares-of-healthequity-inc-hqy-stock.html

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 6th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.03. The business earned $44.20 million during the quarter. HealthEquity had a net margin of 15.21% and a return on equity of 10.89%. The company’s revenue for the quarter was up 44.9% compared to the same quarter last year. During the same quarter last year, the business earned $0.08 EPS. Equities analysts anticipate that HealthEquity Inc. will post $0.51 earnings per share for the current year.

Several large investors have recently made changes to their positions in the company. BlackRock Inc. boosted its stake in shares of HealthEquity by 56.5% in the second quarter. BlackRock Inc. now owns 3,594 shares of the company’s stock worth $109,000 after buying an additional 1,297 shares during the period. PineBridge Investments L.P. raised its stake in shares of HealthEquity by 4.3% in the second quarter. PineBridge Investments L.P. now owns 4,482 shares of the company’s stock worth $137,000 after buying an additional 186 shares in the last quarter. Teacher Retirement System of Texas raised its stake in shares of HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock worth $184,000 after buying an additional 1,850 shares in the last quarter. Denver Investment Advisors LLC bought a new stake in shares of HealthEquity during the second quarter worth approximately $203,000. Finally, Mason Street Advisors LLC bought a new stake in shares of HealthEquity during the second quarter worth approximately $210,000. Institutional investors and hedge funds own 91.41% of the company’s stock.

A number of research analysts have issued reports on HQY shares. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “strong-buy” rating and set a $28.00 target price for the company in a report on Tuesday, May 24th. SunTrust Banks Inc. increased their target price on shares of HealthEquity from $34.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, June 8th. Wells Fargo & Co. reaffirmed a “buy” rating on shares of HealthEquity in a report on Wednesday, June 8th. Leerink Swann reissued an “outperform” rating and set a $33.00 price objective (up from $30.00) on shares of HealthEquity in a research note on Wednesday, June 8th. Finally, TheStreet raised shares of HealthEquity from a “sell” rating to a “hold” rating in a research note on Tuesday, June 7th. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. HealthEquity has an average rating of “Buy” and a consensus target price of $36.00.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.